 NEW YORK, Sept. 22, 2021 PRNewswire -- Q BioMed Inc. OTCQB: QBIO a commercial stage biotechnology acceleration company, is pleased to provide an update on its partner asset MAN-19 for the treatment of Acute Respiratory Distress Syndrome ARDS, a condition caused by viral infections in the lungs including COVID-19. 